The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Open accessAbstract
The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of “active compound” has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of ‘organ-on chip’ and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–262 of 262
Traditional Chinese Medicine for Treatment of Alcoholism: From Ancient to Modern
Liu, Q., Lawrence, A. J., & Liang, J. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11008609 · Cited by 44
Prognostic and Predictive Biomarkers in Cancer
Nair, M., Sandhu, S. S., & Sharma, A. K. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140506111118 · Cited by 44
Bastian, L., Hof, J., Pfau, M., Fichtner, I., Eckert, C., Henze, G., Prada, J., von Stackelberg, A., Seeger, K., & Shalapour, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1511 · Cited by 43
Ji, S., Fattahi, A., Raffel, N., Hoffmann, I., Beckmann, M. W., Dittrich, R., & Schrauder, M. G. (2017) · European journal of medical research · doi:10.1186/s40001-017-0293-6 · Cited by 43
Exploiting big data for critical care research
Docherty, A. B., & Lone, N. I. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000228 · Cited by 42
Pharmaceuticals from natural products: current trends
Seidl, P. R. (2002) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652002000100011 · Cited by 42
Thomford, N. E., Dzobo, K., Chopera, D., Wonkam, A., Maroyi, A., Blackhurst, D., & Dandara, C. (2016) · Molecules · doi:10.3390/molecules21070891 · Cited by 42
Self-citationBuilding on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing
Sullivan, K. M., Manuppello, J. R., & Willett, C. (2014) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2014.907203 · Cited by 41
Thomford, N. E., Awortwe, C., Dzobo, K., Adu, F., Chopera, D., Wonkam, A., Skelton, M., Blackhurst, D., & Dandara, C. (2016) · Molecules · doi:10.3390/molecules21020211 · Cited by 41
Self-citationIdentification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system
Chen, X., Xiang, L., Shi, L., Li, G., Yao, H., Han, J., Lin, Y., Song, J., & Chen, S. (2017) · Scientific Reports · doi:10.1038/srep42325 · Cited by 41
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) for Quantitative Proteomics
Hoedt, E., Zhang, G., & Neubert, T. A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-06068-2_5 · Cited by 41
Koppitz, M., & Eis, K. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.04.005 · Cited by 40
Metabolic Engineering: Advances in Modeling and Intervention in Health and Disease
Yarmush, M. L., & Banta, S. A. (2003) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.5.031003.163247 · Cited by 40
Genomic profile of the plants with pharmaceutical value
Gantait, S., Debnath, S., & Ali, M. N. (2014) · 3 Biotech · doi:10.1007/s13205-014-0218-9 · Cited by 39
Taxonomy and environmental policy
Samper, C. (2004) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2004.1476 · Cited by 39
Morford, L. L., Bowman, C., Blanset, D. L., Bøgh, I. B., Chellman, G. J., Halpern, W., Weinbauer, G. F., & Coogan, T. P. (2011) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20305 · Cited by 37
Target identification strategies in plant chemical biology
Dejonghe, W., & Russinova, E. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00352 · Cited by 37
Spotting and designing promiscuous ligands for drug discovery
Schneider, P., Röthlisberger, M., Reker, D., & Schneider, G. (2015) · Chemical Communications · doi:10.1039/c5cc07506h · Cited by 37
Genetic and proteomic approaches to identify cancer drug targets
Roti, G., & Stegmaier, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.543 · Cited by 36
Use of big data in drug development for precision medicine
Kim, R. S., Goossens, N., & Hoshida, Y. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1174062 · Cited by 36
Challenges and recent advances in affinity purification of tag-free proteins
Guan, D., & Chen, Z. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1509-2 · Cited by 35
Yang, T.-Y., Hsu, L.-I., Chiu, A. W., Pu, Y., Wang, S.-H., Liao, Y., Wu, M., Wang, Y., Chang, C., Lee, T., et al. (2013) · Environmental Research · doi:10.1016/j.envres.2013.10.006 · Cited by 35
LaPorte, T. L., & Wang, C. (2007) · PubMed · Cited by 35
Guo, X., Long, J., Zeng, C., Michailidou, K., Ghoussaini, M., Bolla, M. K., Wang, Q., Milne, R. L., Shu, X., Cai, Q., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0363 · Cited by 34
Indian Herbs for the Treatment of Neurodegenerative Disease
Mannangatti, P., & Naidu, K. N. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_17 · Cited by 34
Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis
Ipsaro, J. J., Shen, C., Arai, E., Xu, Y., Kinney, J. B., Joshua‐Tor, L., Vakoc, C. R., & Shi, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172177 · Cited by 31
Thomford, N. E., Dzobo, K., Adu, F., Chirikure, S., Wonkam, A., & Dandara, C. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.023 · Cited by 31
Self-citationGenerative Models for Chemical Structures
White, D. J., & Wilson, R. C. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9004089 · Cited by 29
Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
Kawajiri, H., Takashima, T., Kashiwagi, S., Noda, S., Onoda, N., & Hirakawa, K. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.992418 · Cited by 29
Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma
Beck, A., Eberherr, C., Hagemann, M., Cairo, S., Häberle, B., Vokuhl, C., von Schweinitz, D., & Kappler, R. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1235664 · Cited by 28
Chusri, S., Siriyong, T., Na-Phatthalung, P., & Voravuthikunchai, S. P. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60074-2 · Cited by 27
Genetics, genomics, and their relevance to pathology and therapy
Ombrello, M. J., Sikora, K. A., & Kastner, D. L. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.05.001 · Cited by 27
From Smallpox to Big Data: The Next 100 Years of Epidemiologic Methods
Gange, S. J., & Golub, E. T. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv150 · Cited by 27
Forces of Habit: Drugs and the Making of the Modern World
Edwards, G. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.t01-9-00166.x · Cited by 26
Animal models of efficacy to accelerate drug discovery in malaria
Jiménez-Díaz, M. B., Viera, S., Fernández‐Álvaro, E., & Angulo‐Barturen, Í. (2013) · Parasitology · doi:10.1017/s0031182013000991 · Cited by 26
Identification of protein binding partners of small molecules using label-free methods
Saxena, C. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1227316 · Cited by 24
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) for Quantitative Proteomics.
Hoedt, E., Zhang, G.-A., & Neubert, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-15950-4_31 · Cited by 23
How “drug-like” are naturally occurring anti-cancer compounds?
Ntie‐Kang, F., Lifongo, L. L., Judson, P. N., et al. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2069-z · Cited by 22
Thomford, N. E., Mkhize, B., Dzobo, K., Mpye, K. L., Rowe, A., Parker, M. I., Wonkam, A., Skelton, M., September, A. V., & Dandara, C. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0117 · Cited by 22
Self-citationDetermining drug efficacy parameters for mathematical models of influenza
Beggs, N. F., & Dobrovolny, H. M. (2015) · Journal of Biological Dynamics · doi:10.1080/17513758.2015.1052764 · Cited by 21
Ginseng (Panax sp.) proteomics: an update
Kim, S. W., Lee, S. H., Min, C. W., Jo, I. H., Bang, K. H., Hyun, D.-Y., Agrawal, G. K., Rakwal, R., Zargar, S. M., Gupta, R., et al. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0283-y · Cited by 21
Simmonds, P., Loomis, E. W., & Curry, E. W. (2017) · Genome Medicine · doi:10.1186/s13073-017-0443-z · Cited by 21
Semantic inference using chemogenomics data for drug discovery
Zhu, Q., Sun, Y., Challa, S., Ding, Y., Lajiness, M. S., & Wild, D. J. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-256 · Cited by 20
Mapping small molecule binding data to structural domains
Krüger, F. A., Rostom, R., & Overington, J. P. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s17-s11 · Cited by 19
Tang, H., Duggan, S., Richardson, P. L., Marin, V. L., Warder, S. E., & McLoughlin, S. M. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115622431 · Cited by 19
Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets
Barbosa, S., Carreira, S., Bailey, D., Abaitua, F., & O’Hare, P. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-04-0247 · Cited by 18
2010: A new beginning for biodiversity?
Barbault, R. (2011) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2011.02.002 · Cited by 18
Querying Genomic Databases: Refining the Connectivity Map
Segal, M. R., Xiong, H., Bengtsson, H. L., Bourgon, R., & Gentleman, R. C. (2012) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1715 · Cited by 17
QSAR/QSPR as an Application of Artificial Neural Networks
Montañez-Godínez, N., Martínez-Olguín, A. C., Deeb, O., Garduño‐Juárez, R., & Ramírez‐Galicia, G. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2239-0_19 · Cited by 17
Srivastava, K. D., Sampson, H. A., Emala, C. W., & Li, X.-M. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00423.2012 · Cited by 15
Jin, L., Wang, D., Gooden, D. M., Ball, C. H., & Fitzgerald, M. C. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02658 · Cited by 15
Strickland, E. C., Geer, M. A., Hong, J., & Fitzgerald, M. C. (2013) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-013-0754-2 · Cited by 14
Microstructured reactors as tools for the intensification of pharmaceutical reactions and processes.
Chin, P., Barney, W. S., & Pindzola, B. A. (2009) · PubMed · Cited by 13
Cracking the ENCODE: From transcription to therapeutics
Mehta, G., Jalan, R., & Mookerjee, R. P. (2013) · Hepatology · doi:10.1002/hep.26449 · Cited by 11
Integrating genomics across drug discovery and development
Debouck, C. M. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.09.011 · Cited by 10
Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation
Mwapagha, L. M., Tiffin, N., & Parker, M. I. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00258 · Cited by 9
Selecting the Best Drugs for Phase I Clinical Development and Beyond
Loong, H. H.-F., & Siu, L. L. (2013) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2013.33.469 · Cited by 8
Context-specific functional module based drug efficacy prediction
Hwang, W., Choi, J., Kwon, M., & Lee, D. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1078-6 · Cited by 8
Novick, D., & Rubinstein, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-439-1_12 · Cited by 7
Tsugawa, J., Onozawa, R., Fukae, J., Mishima, T., Fujioka, S., & Tsuboi, Y. (2015) · BMC Neurology · doi:10.1186/s12883-015-0360-y · Cited by 7
Coping with Polypharmacology by Computational Medicinal Chemistry
Schneider, G., Reker, D., Rodrigues, T., & Schneider, P. (2014) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2014.648 · Cited by 6
Reynolds, C. R., Muggleton, S., & Sternberg, M. J. E. (2015) · Molecular Informatics · doi:10.1002/minf.201400162 · Cited by 3
Cited by
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Plant-Derived Natural Products: A Source for Drug Discovery and Development
Chaachouay, N., & Zidane, L. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010011 · Cited by 1,081
Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
Pharmacological potential of ginseng and its major component ginsenosides
Ratan, Z. A., Haidere, M. F., Hong, Y. H., Park, S. H., Lee, J.-O., Lee, J., & Cho, J. Y. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.02.004 · Cited by 543
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Metadata
- Authors
- Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-05-25
- Volume
- 19
- Issue
- 6
- Pages
- 1578
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2803627340
- Cited by
- 1,241
- References
- 262
- FWCI
- 69.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.